Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v11-FR
Language English French
Date Updated 2018-02-08 2018-02-07
Drug Identification Number 02084287 02084287
Brand name NEURONTIN CAP 400MG NEURONTIN CAP 400MG
Common or Proper name NEURONTIN NEURONTIN
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 400MG 400MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 capsules 100 capsules
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-19 2017-12-19
Estimated end date
Actual end date 2018-02-07 2018-02-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments